Redistributed Manufacturing in Deployed Medical Care Network Plus
Lead Research Organisation:
University of the West of England
Department Name: Faculty of Business and Law
Abstract
Re-Distributed Manufacture (RDM) is defined as: "Technology, systems and strategies that change the economics and organisation of manufacturing, particularly with regard to location and scale" . In healthcare, RDM involves bringing production closer to the point of clinical need or use, enhancing the capability to deliver personalised medicine. The EPSRC funded Re-Distributed Manufacturing in Healthcare Network (RiHN- www.RiHN.org.uk) was launched in Feb 2015 and delivered by a consortium of six universities (UWE, Loughborough, Nottingham, Cambridge, Newcastle & Brunel), representing disciplines from both the social sciences and engineering and led an agenda to advance the impact of UK medical manufacturing.
One area of significant research interest identified by RiHN has been the potential value of implementing RDM approaches in deployed medical care. Whilst RDM includes the notion of a shift from centralised towards decentralised production, extant research continues to assume a degree of stable environmental conditions and fixed static location (e.g. hospitals/clinics/home). However, RDM can deliver life-saving benefits in mobile medical scenarios, where there is urgent and unforeseen demand in changing and remote locations, such as in response to natural disasters and emergencies (e.g. the Ebola crisis, Cyclone Idai and recent terrorist attacks), and the rapid treatment of injured military personnel in the field. This often requires a reverse supply chain perspective, starting with the requirement based on patient need. There are a variety of medical conditions that could benefit from rapid response treatments closer to the site of a medical emergency or in field hospitals; these include (but not limited to) blast injuries to skin and tissue, haemorrhagic shock and fractures.
The project will be led by a multi-disciplinary team bringing together subject matter experts that rarely meet, such as experts in trauma care, emergency medicine, innovation management and manufacturing, and will achieve the following outputs:
- A review of current research capability and knowledge- sharing of current breakthroughs
- Enhancing understanding of the use of RDM in deployed medical care
- Identification of and development of promising RDM technologies that support treatment pathways in deployed operations
- Capture of military and civilian emergency medical requirements and applications for RDM
- Systematic identification and comparison of needs, applications, technologies and resources
The overall outcome for the research will be the creation of 'communities of practice', producing real world demonstrators covering both the business and technical aspects of implementing RDM in deployed medical care, bringing the potential to advance the UK's capability in RDM, delivering impact to clinicians, practitioners and patients. The research will help shape how the UK Ministry of Defence, prime contractors in the defence sector, emergency and urgent care services and UK Research Council proceed with future R&D investment and resourcing. The outputs of the project will also be disseminated through a website, presentations at relevant national and international conferences, and research centres and a Special Issue journal (Health Services Management Research) and presenting the findings of the project at a showcase event. A final report will be produced, sent electronically to all interested parties, and made available digitally and via social media.
One area of significant research interest identified by RiHN has been the potential value of implementing RDM approaches in deployed medical care. Whilst RDM includes the notion of a shift from centralised towards decentralised production, extant research continues to assume a degree of stable environmental conditions and fixed static location (e.g. hospitals/clinics/home). However, RDM can deliver life-saving benefits in mobile medical scenarios, where there is urgent and unforeseen demand in changing and remote locations, such as in response to natural disasters and emergencies (e.g. the Ebola crisis, Cyclone Idai and recent terrorist attacks), and the rapid treatment of injured military personnel in the field. This often requires a reverse supply chain perspective, starting with the requirement based on patient need. There are a variety of medical conditions that could benefit from rapid response treatments closer to the site of a medical emergency or in field hospitals; these include (but not limited to) blast injuries to skin and tissue, haemorrhagic shock and fractures.
The project will be led by a multi-disciplinary team bringing together subject matter experts that rarely meet, such as experts in trauma care, emergency medicine, innovation management and manufacturing, and will achieve the following outputs:
- A review of current research capability and knowledge- sharing of current breakthroughs
- Enhancing understanding of the use of RDM in deployed medical care
- Identification of and development of promising RDM technologies that support treatment pathways in deployed operations
- Capture of military and civilian emergency medical requirements and applications for RDM
- Systematic identification and comparison of needs, applications, technologies and resources
The overall outcome for the research will be the creation of 'communities of practice', producing real world demonstrators covering both the business and technical aspects of implementing RDM in deployed medical care, bringing the potential to advance the UK's capability in RDM, delivering impact to clinicians, practitioners and patients. The research will help shape how the UK Ministry of Defence, prime contractors in the defence sector, emergency and urgent care services and UK Research Council proceed with future R&D investment and resourcing. The outputs of the project will also be disseminated through a website, presentations at relevant national and international conferences, and research centres and a Special Issue journal (Health Services Management Research) and presenting the findings of the project at a showcase event. A final report will be produced, sent electronically to all interested parties, and made available digitally and via social media.
Planned Impact
In summary, during a series of sandpit and workshop events, run by the EPSRC funded RiHN, the potential value of implementing RDM approaches in deployed, frontline operations was identified. Working with MoD Defence Medical Services (DMS), members of the RiHN team seek to open up a new line of investigation that has the potential to radically transform support to medical treatments in deployed operations, where there is urgent and unforeseen demand remote and changeable locations. The proposed Network will allow us to bring together a number of key experts and disciplines and advance a robust, structured agenda for further research with the aim of advancing the UK's capability in RDM and delivering impact to clinicians, practitioners and patients. This agenda will help shape how MoD, defence prime contractors, emergency services and UK Research Council proceed with future R&D investment and resourcing.
Beneficiaries include SMEs and defence prime contractors (suppliers of 3D printers and scanners, and manufacturers specialising in customised parts and therapies), clinicians within the NHS and MoD Defence Medical Services, who will define requirements and will be end users of new technologies and and systems that will allow the rapid, tailored and localised treatments of life-threatening and debilitating injuries, resulting in better patient outcomes. If there were a significant adoption of RDM, soldiers would receive an enhanced level of critical care when it is most required, which has the potential to reduce complications and long-term care costs incurred by the Ministry of Defence.
Clinicians operating in deployed operations often have to administer treatments in extreme conditions, facing needs that may help define future take up by the NHS. The practice of emergency and military medicine can be employed to evaluate novel healthcare approaches, and identify where RDM can add the most value in healthcare delivery.
Finally, the academic community will benefit from the Network, which will bring together those from diverse backgrounds to investigate applications beyond the mainstream clinical settings. For those from the social sciences, this will allow them to explore the role of lead users in shaping novel manufacturing technologies and systems, and an improved comprehension of the diffusion of disruptive innovations. For those from engineering and science, they will be provided with an insight into the working environment and issues of emergency and military medicine. All academic participants will have the opportunity to explore and critique their ideas leading to further proposals investigating the feasibility of RDM applications.
The proposed Network is well connected to key researchers in engineering and management, centres of innovative manufacturing, and specialists in military and emergency medicine - ensuring effective participation, dissemination and exploitation.
Beneficiaries include SMEs and defence prime contractors (suppliers of 3D printers and scanners, and manufacturers specialising in customised parts and therapies), clinicians within the NHS and MoD Defence Medical Services, who will define requirements and will be end users of new technologies and and systems that will allow the rapid, tailored and localised treatments of life-threatening and debilitating injuries, resulting in better patient outcomes. If there were a significant adoption of RDM, soldiers would receive an enhanced level of critical care when it is most required, which has the potential to reduce complications and long-term care costs incurred by the Ministry of Defence.
Clinicians operating in deployed operations often have to administer treatments in extreme conditions, facing needs that may help define future take up by the NHS. The practice of emergency and military medicine can be employed to evaluate novel healthcare approaches, and identify where RDM can add the most value in healthcare delivery.
Finally, the academic community will benefit from the Network, which will bring together those from diverse backgrounds to investigate applications beyond the mainstream clinical settings. For those from the social sciences, this will allow them to explore the role of lead users in shaping novel manufacturing technologies and systems, and an improved comprehension of the diffusion of disruptive innovations. For those from engineering and science, they will be provided with an insight into the working environment and issues of emergency and military medicine. All academic participants will have the opportunity to explore and critique their ideas leading to further proposals investigating the feasibility of RDM applications.
The proposed Network is well connected to key researchers in engineering and management, centres of innovative manufacturing, and specialists in military and emergency medicine - ensuring effective participation, dissemination and exploitation.
Organisations
- University of the West of England, United Kingdom (Lead Research Organisation)
- Defence Science & Technology Laboratory (DSTL) (Collaboration)
- Quay Pharma (Collaboration)
- Ministry of Defence (MOD) (Collaboration)
- South Tees Hospitals NHS Foundtn Trust (Collaboration)
- Centillion Technology (Collaboration)
- East Midlands Medilink (Collaboration)
- Centillion Technology Systems (CTS) (Collaboration)
- Centre for Process Innovation (CPI) (Collaboration)
- Research Complex at Harwell (Collaboration)
- Porton Biopharma Ltd (Collaboration)
- Defence Medical Services (Collaboration)
- Innovate UK, Lusaka (Collaboration)
- Scitech Engineering Ltd, Woking (Collaboration)
- Energy Scitech Ltd, United Kingdom (Project Partner)
- Centillion Technology Ltd (Project Partner)
- Royal Centre for Defence Medicine (Project Partner)
Publications

Fosso Wamba S
(2021)
Guest editorialEmerging technologies in emergency situations
in International Journal of Operations & Production Management

Kayali Y
(2022)
Effect of printing parameters on microscale geometry for 3D printed lattice structures
in Materials Today: Proceedings

Moradlou H
(2020)
Buyer-supplier collaboration during emerging technology development
in Production Planning & Control

Phillips W
(2021)
Responding to information asymmetry in crisis situations: innovation in the time of the COVID-19 pandemic
in Public Management Review

Phillips W
(2022)
Global Value Chain Reconfiguration and COVID-19: Investigating the Case for More Resilient Redistributed Models of Production
in California Management Review

Willis S
(2022)
An automated design pipeline for transparent facial orthoses: A clinical study
in The Journal of Prosthetic Dentistry

Willis S
(2022)
An automated design pipeline for transparent facial orthoses: A clinical study.
in The Journal of prosthetic dentistry

Zhang B
(2021)
New insights into the effects of porosity, pore length, pore shape and pore alignment on drug release from extrusionbased additive manufactured pharmaceuticals
in Additive Manufacturing
Title | A novel design-through-manufacture approach to transparant face orthosis for deployed medical environments. |
Description | Feasibility study video |
Type Of Art | Film/Video/Animation |
Year Produced | 2021 |
Impact | Provided a publically available (via RiHN website/social media) outline of the RiHN programme's funded project investigating the potential of 3D printing of facial orthosis for use in deployed medicine. |
URL | https://www.youtube.com/watch?v=w3Glsr8nW1w |
Title | AMPlify: redistributed manufacturing of antimicrobial peptides for wound care |
Description | RiHN feasibility study video |
Type Of Art | Film/Video/Animation |
Year Produced | 2021 |
Impact | Provided a publically available (via RiHN website/social media) outline of the RiHN programme's funded project investigating the potential of antimicrobial peptides for wound care in deployed medicine. |
URL | https://www.youtube.com/watch?v=XwxnS0Pij9k |
Title | Combining Orthobiologics, Antimicrobial and Angiogenic Properties for Rapid Treatment of Bone Repair in Deployed Settings |
Description | RiHN feasibility study video |
Type Of Art | Film/Video/Animation |
Year Produced | 2021 |
Impact | Provided a publically available (via RiHN website/social media) outline of the RiHN programme's funded project investigating the potential of orthobiologics for use in deployed medicine. |
URL | https://www.youtube.com/watch?v=Oyd3Vg5UiEU |
Title | Decentralised manufacture of combi-pills at point of care |
Description | RiHN feasibility study video |
Type Of Art | Film/Video/Animation |
Year Produced | 2021 |
Impact | Provided a publically available (via RiHN website/social media) outline of the RiHN programme's funded project investigating the potential of decentralised manufacture of combi-pills for use in deployed medicine. |
URL | https://www.youtube.com/watch?v=Q07DXK5visQ |
Title | Handheld Electrospinning of Antimicrobial Laminar Structures (HEALS) for simultaneous fabrication and application of micro and nanofibrous wound dressings. |
Description | RiHN Feasability study video |
Type Of Art | Film/Video/Animation |
Year Produced | 2021 |
Impact | Provided an outline of the RiHN programme's funded project investigating the potential of electrospinning of wound dressings for deployed medical care. |
URL | https://www.youtube.com/watch?v=U7qK3p5mU9k |
Title | Proof-of-concept of long-term storage of functional extra-cellular vesicles for application in accelerated soft-tissue and fracture healing |
Description | RiHN feasibility study video |
Type Of Art | Film/Video/Animation |
Year Produced | 2021 |
Impact | Provided a publically available (via RiHN website/social media) outline of the RiHN programme's funded project investigating the potential long-term storage of extra-cellular vesicles for wound healing in deployed medicine. |
URL | https://www.youtube.com/watch?v=rgIuzUaFjBI |
Description | So far the Network has funded 13 feasibility studies that are undertaking research into redistributed manufacturing in four priority areas: clinical fluids manufacturing, additive layer manufacturing,cell and tissue manufacturing and pharmaceutical manufacturing. Some of these feasibility studies have completed and their findings presented in their final reports which areavailable on the RiHN website |
Exploitation Route | The outcomes of the feasibility studies shoudl hopefully lead to further funding of larger scale research projects. Some of the techologies being developed by the studies have gone to be field tested in a deployed medical scenario and folowing the outcome of the testing may move towards being used by practitioners of deployed medical care |
Sectors | Aerospace, Defence and Marine,Healthcare,Government, Democracy and Justice,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology |
URL | https://rihn.org.uk/fundedprojects/ |
Description | The Programme has been impacted by the Covid-19 pandemic and so did not commence until the beginning of July 2020. However, Co-Is on the Programme, notably Prof Harris Makatoris, Prof Phillips and Dr Sam Roscoe have been interviewed by various media outlets regarding the impact of Covid on supply chains and healthcare manufacturing. Dr Sam Roscoe has provided recommendations to the International Trade Committee regarding building resilience into UK supply chains and these recommendations have been taken up by the UK Government and have resulted in a foundational level supply chain capability development programme which taught members of the DIT's Global Supply Chains Directorate how to identify the early warning signs of supply chain disruptions and develop strategies for overcoming disruptions. |
First Year Of Impact | 2020 |
Sector | Aerospace, Defence and Marine,Healthcare,Government, Democracy and Justice,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology |
Impact Types | Societal,Economic,Policy & public services |
Description | Department of International Trade, Global Supply Chains Directorate - creation of supply chain capability development programme |
Geographic Reach | Multiple continents/international |
Policy Influence Type | Influenced training of practitioners or researchers |
Description | Artificial Intelligence-driven, Decentralized Production for Advanced Therapies in the Hospital (AIDPATH) |
Amount | € 9,860,991 (EUR) |
Funding ID | 101016909 |
Organisation | European Commission |
Sector | Public |
Country | European Union (EU) |
Start | 01/2021 |
End | 12/2024 |
Description | JOINT EXPERIMENTATION RESEARCH AND INNOVATION (JERI) |
Amount | £123,600 (GBP) |
Organisation | Defence Science & Technology Laboratory (DSTL) |
Sector | Public |
Country | United Kingdom |
Start | 03/2022 |
End | 04/2023 |
Description | Redistributed Manufacturing in Healthcare: Establishing UWE as a Centre of Excellence |
Amount | £9,685 (GBP) |
Organisation | University of the West of England |
Sector | Academic/University |
Country | United Kingdom |
Start | 03/2022 |
End | 09/2022 |
Description | RiHN Feasibility Study - Proof-of-concept of long-term storage of functional extra-cellular vesicles for application in accelerated soft-tissue and fracture healing |
Amount | £15,645 (GBP) |
Organisation | Defence Science & Technology Laboratory (DSTL) |
Sector | Public |
Country | United Kingdom |
Start | 03/2021 |
End | 10/2021 |
Description | Centillion Technology |
Organisation | Centillion Technology |
Country | United Kingdom |
Sector | Private |
PI Contribution | Provided sharing of updates and insights from the research programme. Facilitated their involvement in a pharma RDM feasibility study |
Collaborator Contribution | Sharing of RiHN feasibility study funding competition amongst their network Staff support and representation at programme meetings Offer to provide access to equipment and materials for the relevant pharma feasibility study team Offer to participate in meetings, workshops and events |
Impact | Pharmaceuticals manufacturing |
Start Year | 2020 |
Description | Centre for Process Innovation |
Organisation | Centre for Process Innovation (CPI) |
Country | United Kingdom |
Sector | Private |
PI Contribution | Sharing of progress on the research programme, details of feasibility studies and exploration of alignment and collaboration. |
Collaborator Contribution | Sharing of RiHN feasibility study funding competition amongst their network Offer to run innovation clinics for all feasibility study teams Offer to link CPI staff to relevant feasibility study teams to explore collaborative opportunities Offer to support feasibility study team with follow-on technology-development bids as a partner organisation |
Impact | Additive manufacturing Cell and tissue therapies Clinical fluids Pharmaceuticals |
Start Year | 2020 |
Description | Dstl - Project Mentor for RiHN funded feasibility study led by Keele University |
Organisation | Defence Science & Technology Laboratory (DSTL) |
Country | United Kingdom |
Sector | Public |
PI Contribution | Facilitated Dstl co-funding and commitment to support the feasibility study with a dedicate project mentor Entered into a contract with Dstl for this purpose. |
Collaborator Contribution | Dedicated technical research advice and guidance Facilitated access to related researchers involved in military and emergency medicine Sharing of past knowledge and research in this area |
Impact | Cell and tissue therapies Regenerative medicine Advanced manufacturing |
Start Year | 2021 |
Description | Harwell Campus and STFC |
Organisation | Research Complex at Harwell |
Country | United Kingdom |
Sector | Public |
PI Contribution | Provided updates and insights from the programme. Also explored opportunities for co-funding |
Collaborator Contribution | Sharing of RiHN feasibility study funding competition amongst their network Offer to connect their organisations on-site to feasibility study teams Offer to facilitate support for feasibility study teams seeking to test their propositions using Harwell facilities |
Impact | Advanced manufacturing Cross-sector innovation SME innovation Spin outs |
Start Year | 2020 |
Description | Industry Partner |
Organisation | Porton Biopharma LTD |
Country | United Kingdom |
Sector | Private |
PI Contribution | Provided information on latest advances in RDM |
Collaborator Contribution | Involved in reviewing documents and mentoring feasibility studies |
Impact | No outputs as yet |
Start Year | 2020 |
Description | MOD Defence Equipment and Support |
Organisation | Ministry of Defence (MOD) |
Department | Defence Equipment and Support |
Country | United Kingdom |
Sector | Public |
PI Contribution | Provided an introduction to the programme to various parts of the DE&S organisation involved in advancing the local production agenda (i.e. additive manufacturing) Sharing of insights and findings so far and discussion of mutual objectives |
Collaborator Contribution | Provided expertise and awareness of the value of RiHN research to MOD and DE&S Offer to conduct some joint-analysis activities to inform the business case for innovation adoption Offer to open doors relevant communities in defence working in the same area to compare approaches and avoid duplication |
Impact | Defence Acquisition Supply chain management Military and emergency medicine Defence innovation |
Start Year | 2020 |
Description | Medilink East Midlands |
Organisation | East Midlands Medilink |
Country | United Kingdom |
Sector | Private |
PI Contribution | RiHN ran a Special Interest Group on redistributed manufacturing for East Midlands Medilinks members presenting the RiHn feasibility studies and running a workshop on value chain mapping |
Collaborator Contribution | Medilinks have promoted the work of RiHN via its website and social media and hosted the Special Interest Group where RiHN launched the feasibility studies |
Impact | Supply Chain Special Interest Group |
Start Year | 2015 |
Description | R&D, James Cook University Hospital |
Organisation | James Cook University Hospital |
Country | United Kingdom |
Sector | Hospitals |
PI Contribution | Sharing of progress for the research programme and discussion of collaborative opportunities |
Collaborator Contribution | Sharing of RiHN feasibility study funding competition amongst their network Research linkages to CPI Offer to use a bio-incubator on-site for feasibility study teams Offer to provide an NHS test-bed for feasibility study teams Linking up and networking to colleagues in MoD via their partnership |
Impact | Medical innovation |
Start Year | 2020 |
Description | RiHN Network Plus Advisory Board 2020-2022 |
Organisation | Centillion Technology Systems (CTS) |
Country | Australia |
Sector | Private |
PI Contribution | The research team delivered presentations and thought leadership as well as updates and insights from the research programme. |
Collaborator Contribution | Delivered expert advice and guidance on current developments in industry, academia and public sector innovation. This included access to networks, |
Impact | - Collaboration with feasibility study teams - Access to experts - Access to reports and data |
Start Year | 2020 |
Description | RiHN Network Plus Advisory Board 2020-2022 |
Organisation | Centre for Process Innovation (CPI) |
Country | United Kingdom |
Sector | Private |
PI Contribution | The research team delivered presentations and thought leadership as well as updates and insights from the research programme. |
Collaborator Contribution | Delivered expert advice and guidance on current developments in industry, academia and public sector innovation. This included access to networks, |
Impact | - Collaboration with feasibility study teams - Access to experts - Access to reports and data |
Start Year | 2020 |
Description | RiHN Network Plus Advisory Board 2020-2022 |
Organisation | Defence Medical Services |
Country | United Kingdom |
Sector | Hospitals |
PI Contribution | The research team delivered presentations and thought leadership as well as updates and insights from the research programme. |
Collaborator Contribution | Delivered expert advice and guidance on current developments in industry, academia and public sector innovation. This included access to networks, |
Impact | - Collaboration with feasibility study teams - Access to experts - Access to reports and data |
Start Year | 2020 |
Description | RiHN Network Plus Advisory Board 2020-2022 |
Organisation | Defence Science & Technology Laboratory (DSTL) |
Country | United Kingdom |
Sector | Public |
PI Contribution | The research team delivered presentations and thought leadership as well as updates and insights from the research programme. |
Collaborator Contribution | Delivered expert advice and guidance on current developments in industry, academia and public sector innovation. This included access to networks, |
Impact | - Collaboration with feasibility study teams - Access to experts - Access to reports and data |
Start Year | 2020 |
Description | RiHN Network Plus Advisory Board 2020-2022 |
Organisation | Innovate UK |
Country | United Kingdom |
Sector | Public |
PI Contribution | The research team delivered presentations and thought leadership as well as updates and insights from the research programme. |
Collaborator Contribution | Delivered expert advice and guidance on current developments in industry, academia and public sector innovation. This included access to networks, |
Impact | - Collaboration with feasibility study teams - Access to experts - Access to reports and data |
Start Year | 2020 |
Description | RiHN Network Plus Advisory Board 2020-2022 |
Organisation | Ministry of Defence (MOD) |
Department | Defence Equipment and Support |
Country | United Kingdom |
Sector | Public |
PI Contribution | The research team delivered presentations and thought leadership as well as updates and insights from the research programme. |
Collaborator Contribution | Delivered expert advice and guidance on current developments in industry, academia and public sector innovation. This included access to networks, |
Impact | - Collaboration with feasibility study teams - Access to experts - Access to reports and data |
Start Year | 2020 |
Description | RiHN Network Plus Advisory Board 2020-2022 |
Organisation | Quay Pharma |
Country | United Kingdom |
Sector | Private |
PI Contribution | The research team delivered presentations and thought leadership as well as updates and insights from the research programme. |
Collaborator Contribution | Delivered expert advice and guidance on current developments in industry, academia and public sector innovation. This included access to networks, |
Impact | - Collaboration with feasibility study teams - Access to experts - Access to reports and data |
Start Year | 2020 |
Description | RiHN Network Plus Advisory Board 2020-2022 |
Organisation | Research Complex at Harwell |
Country | United Kingdom |
Sector | Public |
PI Contribution | The research team delivered presentations and thought leadership as well as updates and insights from the research programme. |
Collaborator Contribution | Delivered expert advice and guidance on current developments in industry, academia and public sector innovation. This included access to networks, |
Impact | - Collaboration with feasibility study teams - Access to experts - Access to reports and data |
Start Year | 2020 |
Description | Scitech |
Organisation | Scitech Engineering Ltd |
Country | United Kingdom |
Sector | Private |
PI Contribution | Provided updates and insights from the research programme |
Collaborator Contribution | Sharing of RiHN feasibility study funding competition amongst their network Offer to provide technical mentioring for any relevant pharma feasibility study teams Offer to provide a cost of goods analysis for feasibility study teams or the programme Offer to provide a validation engineering analysis for the programme Offer to use meeting and conference facilities on-site |
Impact | Pharmaceuticals Manufacturing |
Start Year | 2020 |
Description | Businesss Insider (Sept 21st, 2020) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Discusses the rollout of a COVID-19 vaccine. Includes interview with Dr Sam Roscoe, Co-I on RDM in Deployed Operations Network Plus and also draws on findings on the research undertook for RiHN |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.businessinsider.com/covid-19-vaccine-experts-warn-glass-vials-planes-storage-shortage-20... |
Description | Chemistry World (Oct 15th, 2020) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Article discussing resilience and redundancy as key factors for domestic manufacturing. Includes interview with Dr Sam Roscoe, Co-I on RDM in Deployed Operations network Plus |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.chemistryworld.com/news/covid-19-highlights-need-to-update-pharma-supply-chains/4012597.... |
Description | Conference Attendance: Regenerative Medicine on the Front Line (Stakeholder Collaboration Day) |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Represented RiHN at the Defense and Security Accelerator (DASA) stakeholder collaboration day, which aimed to encourage collaborative projects in the field of regenerative medicine in the deployed healthcare. Networked with, and established new contacts/collaborators from both Defense Medical Services and the academic R&D sector. |
Year(s) Of Engagement Activity | 2021 |
Description | Daily Telegraph- Business Reporter (March 25th, 2020) Future of Supply Chain / How Coronavirus is disrupting key supply chains when we need them the most |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Article by Dr Sam Roscoe in The Telegraph (Business Reporter on how Coronavirus is disrupting key supply chains when we need them the most. Dr Roscoe is a CO-I on the RDM in Deployed Operations Network Plus and his discussion is informed by research he undertook for RiHN |
Year(s) Of Engagement Activity | 2020 |
URL | https://business-reporter.co.uk/2020/03/25/how-coronavirus-is-disrupting-key-supply-chains-when-we-n... |
Description | Delaware Consulting Research insight report (July 7th, 2020) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Industry/Business |
Results and Impact | Report that considers "Innovation driven by necessity -Why flexibility and transformation are key for manufacturers to deliver in uncertain times". Dr Sam Roscoe Co-I on RDM in Deployed Operations Network Plus provided the Preface for the Research Insight Report |
Year(s) Of Engagement Activity | 2020 |
URL | https://info.delaware.pro/innovation-research-insight-report?__hstc=221351303.7457f258f6de201cae1c43... |
Description | European Pharmaceutical review (April 8th, 2020): Limiting shortages: steps for the UK to strengthen drug supply. |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Dr Sam Roscoe, Co-I on RDM in Deployed Operations, explains his recommendations for pharmaceutical companies and supermarkets in the UK to limit reliance on deliveries from overseas, to ease the impact of the COVID-19 coronavirus on drug supply chains. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.europeanpharmaceuticalreview.com/article/116439/limiting-shortages-steps-for-the-uk-to-s... |
Description | Focus Group Workshop (Field-Testing) |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | 14 stakeholders (sector coverage: R&D scientists/innovators/entrepreneurs, military and humanitarian 'lead user' representatives, academics/innovation managers) joined a workshop event to examine the potential for developing field-testing opportunities to support the development of R&D innovations targeting the deployed healthcare sector. The purpose was to discuss: - What could field-testing look like? - What are the challenges/barriers, opportunities? - How can we shape a collaborative bid to develop field-testing opportunities? Expert insight from these discussions will help inform and shape a collaborative grant proposal to develop field-testing opportunities for deployed healthcare innovators, and to connect and partner them with lead users and organsations with experience of working in austere deployed environments. |
Year(s) Of Engagement Activity | 2021 |
Description | Global Value Chain Reconfiguration and COVID-19 |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | YouTube video created by california Management review to promote the findings of our research snd based on the article: "Global Value Chain Reconfiguration and COVID-19: Investigating the Case for More Resilient Redistributed Models of Production" by Wendy Phillips, Jens K. Roehrich, Dharm Kapletia, and Elizabeth Alexander The video has sparked furthe rinterest in our the Network and its research and as a result we have been approached by individuals and organisations who are interested in knowing more about our work |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.youtube.com/watch?v=qDPVKr-dXiE |
Description | Interview/comment for international news outlet CNBC |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | RiHN co-investigator Dr Sam Roscoe provided expert opinion on the 2021 gas crisis - highlighting the ripple effects of Brexit on the UK labour market and supply chains. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.cnbc.com/2021/10/18/gas-crisis-labor-shortages-and-supply-chain-chaos-post-brexit-britai... |
Description | Interview/comment for online news outlet Tech Monitor |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | RiHN CoI Dr Sam Roscoe provided expert opinion for an article discussing "Can digital technology prevent supply chain disruptions?", where he highlighted the impact of political intervention upon global supply chains. |
Year(s) Of Engagement Activity | 2021 |
URL | https://techmonitor.ai/leadership/strategy/can-digital-technology-prevent-supply-chain-disruptions#:... |
Description | LSE Business Review (May 19th, 2020) The future of UK supply chains in a disrupted world: Brexit and Covid-19 |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Dr Sam roscoe, Co-I on RDM in Deployed operations bid discusses the future of UK supply chains in a disrupted world: Brexit and Covid-19 |
Year(s) Of Engagement Activity | 2020 |
URL | https://blogs.lse.ac.uk/businessreview/2020/05/19/the-future-of-uk-supply-chains-in-a-disrupted-worl... |
Description | Lombard (Oct, 2020) Reshoring: the key to manufacturing reslience? |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Report on the pros and cons of shaking up their supply chains. Includes interview with Dr Sam Roscoe, Co-I on RDM in Deployed Operations |
Year(s) Of Engagement Activity | 2020 |
URL | https://lombard.contentlive.co.uk/content/reshoring-the-key-to-manufacturing-resilience |
Description | Meet the Guest Editors of the IJOPM Special Issue |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | 32 academics attended a workshop for a Special Issue of the International Journal of Operations and Production Management on "Emerging Technologies in Emergency Situations" f This special issue invites scholars and practitioners to provide insights and contributions to the Operations and Supply Chain Management (O&SCM) field by considering the integration of emerging technologies for emergency situations. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.eventbrite.co.uk/e/112789313874 |
Description | Pharmaceutial Journal (May 6th, 2020) Manufacturer to move hydroxycholorquine production to the UK to avoid shortages |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Reports on Dr Sam Roscoe, Co-I on RDM in Deployed Operations Network Plus address to the House of Commons International Trade Committee on 23 April 2020, His discussion builds on his findings from his RiHN funded research |
Year(s) Of Engagement Activity | 2020 |
URL | https://pharmaceutical-journal.com/article/news/manufacturer-to-move-hydroxychloroquine-production-t... |
Description | Podcast Industry Dive - Dec 17th, 2020 |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Podacst Industry Dive - Dec 17th, 2020 - Money Minutes in partnership with American Express - Futureproofing your supply chain against costly disruptions. Dr Sam Roscoe - RDM in Deployed Operations is interviewed |
Year(s) Of Engagement Activity | 2020 |
URL | https://omny.fm/shows/business-class-money-minutes/futureproofing-your-supply-chain-against-costly-d... |
Description | Point of Care Framework Meeting: 18.03.21 |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Medicines and Healthcare products regulatory Agency (MHRA) Point of Care Framework Meeting which followed up on the two workshops held in 2020 to develop a new regulatory framework for Point of Care (PoC) manufacturing of medicinal products. Developing a new regulatory framework for PoC manufacture is one of the 'innovative regulation' projects in the second Sector Deal of the UK's Life Sciences Industrial Strategy. High level regulatory proposals were presented at this meeting for the new UK regulatory framework which will enable the safe development of this new pharmaceutical sector. At this meeting, participants contributed to: • The proposals for a new regulatory framework which will enable the safe development of this new sector of pharmaceutical manufacture in the UK. • The next stages of the work which will lead to the new regulatory framework. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.eventbrite.co.uk/e/point-of-care-framework-meeting-tickets-143037205131?utm_source=Gov%2... |
Description | Raconteur Magazine (Sept 30th, 2020) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Article in Raconteur Magazine (Sept 30th, 2020) Could reshoring help manufacturers survive COVID? Includes interview with Dr Sam Roscoe, Co-I on RDm in Deployed Operations Network Plus |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.raconteur.net/supply-chain/reshoring-manufacturing-covid/ |
Description | Research to assess possibility of producing healthcare products like PPE at point of need |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Industry/Business |
Results and Impact | Press release from UWE promoting the RiHN Deployed Operations Programme |
Year(s) Of Engagement Activity | 2020 |
Description | Resilient Healthcare in Supply Chains |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | A podcast for Chain Reaction which is a podcast 'All About Supply Chain Advantage' containing regular audio snippets relevant to C suite executives, supply chain professionals, researchers, policy makers in government, students, media commentators and the wider public. New episodes each week discuss hot topics in the news and supply chain ideas relevant to everyone involved in supply chain management. In the episode Prof Wendy Phillips (PI) discusses resilient supply chains in healthcarefocusing on how redistributed manufacturing as a strategy can be used to improve timeliness to meet patient needs better. |
Year(s) Of Engagement Activity | 2022 |
URL | https://podcasts.apple.com/gb/podcast/resilient-supply-chains-in-healthcare-extract/id1552626101?i=1... |
Description | RiHN Funding Webinar |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | RiHN held its first funding webinar on the 17th September 2020 with +70 participants attending. The participants represented over 27 different higher education organisations and a few industry/public sector members. We aimed to provide potential applicants with an overview of the funding competition and an opportunity to ask questions about the research themes and application process. We invited UK researchers to actively engage with us, learn more about our aims and how we are collaborating with stakeholders in the deployed medical care ecosystem. The outcome of this webinar was a high request for application documentation, building on our RiHN membership base to 250 members and later on, we received 22 applications from attendees. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.eventbrite.co.uk/e/rihn-research-funding-qa-webinar-tickets-117407211129# |
Description | Special Interest Group: Point-of-Care Manufacturing |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | RiHN is hosting an online event to discuss the business case for point-of-care redistributed manufacturing (RDM) focussing on additive layer manufacturing and pharmaceutical manufacturing. Talks from Dr. Phil Reeves, Dr. Luke Burke around the benefits of PoC additive manufacturing, and Dr. Sam Roscoe and Prof. Sheng Qi around redistributed manufacturing of pharmaceuticals With senior stakeholders in RDM on the steering panel for this special interest group, their involvement lends weight to the conversation and depth to what "point-of-care" manufacturing means to them. We hope to tackle some of the unique challenges in implementing and validating RDM solutions, determine where in the economic model does RDM makes the most sense, and articulate the benefits to both the providers and end-users. |
Year(s) Of Engagement Activity | 2021 |
URL | https://rihn.org.uk/sig/ |
Description | Special Interest Group: Point-of-Care Manufacturing |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | RiHN is hosting online a series of short talks on the business case for redistributed manufacturing (RDM) in clinical fluid, and cell & tissue manufacturing. Talks from Prof. Nick Medcalf - Innovate UK and Dr. Ifty Ahmed - University of Nottingham, on Cell & Tissue Manufacturing at the point-of-care. Followed by talks from Prof. Darren Reynolds and Dr. Jenni May, on clinical fluid manufacturing and the challenges facing blood transfusion for frontline treatment. With senior stakeholders in RDM on the steering panel for this special interest group, their involvement lends weight to the conversation and depth to what "point-of-care" manufacturing means to them. We hope to tackle some of the unique challenges in implementing and validating RDM solutions, determine where in the economic model does RDM makes the most sense, and articulate the benefits to both the providers and end-users. |
Year(s) Of Engagement Activity | 2021 |
URL | https://rihn.org.uk/sig/ |
Description | Stakeholder engagement with Ministry of Defence staff involved in procurement, support, innovation and military medicine |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | Shared insights and documents from our research programme to help advance the advanced manufacturing innovation adoption agenda within the Ministry of Defence. Also sought to establish research collaboration opportunities for the programme and our funded feasibility studies, facilitating linkages between our respective teams. This will also lead to joint-analysis and opportunities for shaping funding strategies. |
Year(s) Of Engagement Activity | 2020,2021 |
Description | The Future Factory (February 24th, 2020) |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Blog by Dr Sam roscoe, Co-I on RDM in Deployed Operations Network Plus on Supply Chain 4.0 and how emerging technologies are reconfiguring global supply chains. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.thefuturefactory.com/blog/41 |
Description | The Guardian (May 10th, 2020) Drug manufacturing must be brought to UK, NHS bosses and charities tell MPs |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Article in The Guardian where Dr Sam Roscoe,Co-I of RDM in Deployed Operations, building on findings of a feasibility study funded by RiHN Academics calls a "major structural change in supply chains". |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.theguardian.com/business/2020/may/10/bring-drug-manufacturing-to-uk-nhs-mps?CMP=Share_iO... |
Description | UK Trade Policy Observatory (March 24th, 2020) |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Guest blog by Dr Sam Roscoe On Covid-19 Supply Chain Issues |
Year(s) Of Engagement Activity | 2020 |
URL | https://blogs.sussex.ac.uk/uktpo/2020/03/24/covid-19-and-two-key-supply-chains/ |